Suppression of either CD47 or ATP6AP2 alone in MDA-MB-231 cells demonstrated anti-cancer effects, and a double knockdown revealed a synergistic effect and dramatically inhibited tumor development and lung metastasis (Figures 4C, D). Here, ATP6AP2 is linked to cancer.